Annual CFF
-$26.65 M
-$88.73 M-142.94%
December 31, 2023
Summary
- As of February 26, 2025, BVS annual cash flow from financing activities is -$26.65 million, with the most recent change of -$88.73 million (-142.94%) on December 31, 2023.
- During the last 3 years, BVS annual CFF has risen by +$2.92 million (+9.86%).
- BVS annual CFF is now -109.75% below its all-time high of $273.37 million, reached on December 31, 2021.
Performance
BVS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$362.00 K
+$8.21 M+104.61%
September 28, 2024
Summary
- As of February 26, 2025, BVS quarterly cash flow from financing activities is $362.00 thousand, with the most recent change of +$8.21 million (+104.61%) on September 28, 2024.
- Over the past year, BVS quarterly CFF has increased by +$376.00 thousand (+2685.71%).
- BVS quarterly CFF is now -99.79% below its all-time high of $176.31 million, reached on December 31, 2021.
Performance
BVS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$11.74 M
-$7.87 M-203.18%
September 28, 2024
Summary
- As of February 26, 2025, BVS TTM cash flow from financing activities is -$11.74 million, with the most recent change of -$7.87 million (-203.18%) on September 28, 2024.
- Over the past year, BVS TTM CFF has increased by +$14.91 million (+55.96%).
- BVS TTM CFF is now -104.29% below its all-time high of $273.37 million, reached on December 31, 2021.
Performance
BVS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BVS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -142.9% | +2685.7% | +56.0% |
| 3 y3 years | +9.9% | -99.8% | -104.3% |
| 5 y5 years | -101.1% | -99.8% | -104.3% |
BVS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -109.8% | at low | -99.8% | +100.6% | -104.3% | +79.9% |
| 5 y | 5-year | -109.8% | +9.9% | -99.8% | +100.6% | -104.3% | +79.9% |
| alltime | all time | -109.8% | +9.9% | -99.8% | +100.6% | -104.3% | +79.9% |
Bioventus Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $362.00 K(-104.6%) | -$11.74 M(+203.2%) |
| Jun 2024 | - | -$7.84 M(+84.9%) | -$3.87 M(-93.4%) |
| Mar 2024 | - | -$4.24 M(>+9900.0%) | -$58.27 M(+118.6%) |
| Dec 2023 | -$26.65 M(-142.9%) | -$14.00 K(-100.2%) | -$26.65 M(-16.9%) |
| Sep 2023 | - | $8.23 M(-113.2%) | -$32.08 M(-410.0%) |
| Jun 2023 | - | -$62.25 M(-327.3%) | $10.35 M(-87.1%) |
| Mar 2023 | - | $27.38 M(-603.5%) | $80.25 M(+29.3%) |
| Dec 2022 | $62.08 M(-77.3%) | -$5.44 M(-110.7%) | $62.08 M(-74.5%) |
| Sep 2022 | - | $50.65 M(+561.7%) | $243.82 M(+29.1%) |
| Jun 2022 | - | $7.66 M(-16.8%) | $188.82 M(+7.9%) |
| Mar 2022 | - | $9.21 M(-94.8%) | $175.05 M(-36.0%) |
| Dec 2021 | $273.37 M | $176.31 M(-4156.8%) | $273.37 M(+213.6%) |
| Sep 2021 | - | -$4.35 M(-29.0%) | $87.19 M(+153.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$6.12 M(-105.7%) | $34.41 M(+18.0%) |
| Mar 2021 | - | $107.53 M(-1188.5%) | $29.18 M(-198.7%) |
| Dec 2020 | -$29.57 M(+170.0%) | -$9.88 M(-82.7%) | -$29.57 M(+50.2%) |
| Sep 2020 | - | -$57.12 M(+402.9%) | -$19.69 M(-152.6%) |
| Jun 2020 | - | -$11.36 M(-123.3%) | $37.42 M(-23.3%) |
| Mar 2020 | - | $48.78 M(+787.8%) | $48.78 M(+787.8%) |
| Dec 2019 | -$10.95 M(-17.4%) | - | - |
| Dec 2018 | -$13.26 M(-142.4%) | - | - |
| Mar 2016 | - | $5.50 M(+42.7%) | $5.50 M(+42.7%) |
| Dec 2015 | $31.25 M(-570.2%) | - | - |
| Mar 2015 | - | $3.85 M | $3.85 M |
| Dec 2014 | -$6.64 M(-197.7%) | - | - |
| Dec 2013 | $6.80 M | - | - |
FAQ
- What is Bioventus annual cash flow from financing activities?
- What is the all time high annual CFF for Bioventus?
- What is Bioventus annual CFF year-on-year change?
- What is Bioventus quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bioventus?
- What is Bioventus quarterly CFF year-on-year change?
- What is Bioventus TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bioventus?
- What is Bioventus TTM CFF year-on-year change?
What is Bioventus annual cash flow from financing activities?
The current annual CFF of BVS is -$26.65 M
What is the all time high annual CFF for Bioventus?
Bioventus all-time high annual cash flow from financing activities is $273.37 M
What is Bioventus annual CFF year-on-year change?
Over the past year, BVS annual cash flow from financing activities has changed by -$88.73 M (-142.94%)
What is Bioventus quarterly cash flow from financing activities?
The current quarterly CFF of BVS is $362.00 K
What is the all time high quarterly CFF for Bioventus?
Bioventus all-time high quarterly cash flow from financing activities is $176.31 M
What is Bioventus quarterly CFF year-on-year change?
Over the past year, BVS quarterly cash flow from financing activities has changed by +$376.00 K (+2685.71%)
What is Bioventus TTM cash flow from financing activities?
The current TTM CFF of BVS is -$11.74 M
What is the all time high TTM CFF for Bioventus?
Bioventus all-time high TTM cash flow from financing activities is $273.37 M
What is Bioventus TTM CFF year-on-year change?
Over the past year, BVS TTM cash flow from financing activities has changed by +$14.91 M (+55.96%)